secwatch.observer — SEC 8-K summary
======================================

Issuer:     Seer, Inc. (SEER)
CIK:        0001726445
Form:       8-K
Filed at:   2023-08-08T23:59:59+00:00
Accession:  0001628280-23-028203
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Seer Q2 revenue $4M (+11% YoY); slashes FY2023 guidance to $16-18M from $23-25M
-------------------------------------------------------------------------------

- Net loss widened to $23.4M from $22.8M YoY; operating expenses rose 21% to $30.2M.
- Product-related revenue $3.0M including $1.4M related party; service revenue $467K; grant $538K.
- Cash, equivalents and investments at $396M as of June 30, 2023.
- Launched Proteograph XT Assay Kit and STAC service; expanded Thermo Fisher collaboration.
- Guidance cut: now expects FY2023 revenue $16-18M (prior $23-25M), 10% growth at midpoint.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1726445/000162828023028203/0001628280-23-028203-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1726445/000162828023028203/seer-20230808.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-028203

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer